Physician profile
Jay Dinerman
NPI 1740250018
$13,287.51
in general payments reported to CMS, 2019-2025
13 companies · $467 in 2025
The $467 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,698 · 2020: $202 · 2021: $604 · 2022: $1,735 · 2023: $1,217 · 2024: $365 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,424 · Consulting Fee: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,424.41 |
| Consulting Fee | $625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,051.45 | 2019-2025 | Resonate El Icd Vr, Watchman Access System, Accolade Sr |
| Abbott Laboratories | $3,957.06 | 2019-2025 | Tendril, Gallant, Aveir |
| Medtronic Vascular, INC. | $535.95 | 2019-2020 | |
| Biosense Webster, INC. | $257.97 | 2022-2025 | Carto 3 |
| Philips North America LLC | $124.01 | 2021 | |
| Pfizer INC. | $90.16 | 2019-2025 | |
| Medtronic, INC. | $84.72 | 2021-2023 | Diamondtemp Bidirectional Ablation Catheter |
| Gilead Sciences, INC. | $61.89 | 2019 | |
| Novo Nordisk INC | $41.38 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $25.81 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $21.73 | 2020 | |
| Scpharmaceuticals INC. | $17.93 | 2024 | |
| Elutia, INC. | $17.45 | 2025 | Ecm Patch,Pouch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Dinerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.